Shunjie Chen

Dr. Shunjie Chen


Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 November 2021 in International Journal of Nanomedicine
Verified
Journal Article
Open access
PDF file
HWHuaiji Wang
Huaiji Wang
JZJie Zang
Jie Zang
ZZZihan Zhao
Zihan Zhao
QZQin Zhang
Qin Zhang
SCShunjie Chen
Shunjie Chen
The chimeric trait of recruitment by inflammatory signals endows neutrophils with the functionality of migrating to inflamed tissues, which can be utilized to tailor novel drug delivery systems. In this review, we introduce a mechanism of neutrophil-derived drug delivery systems recruited into inflamed sites and provide insight into tumors and inflammation therapy. In particular, the advantages of neutrophils—their endogenous-derived neutrophil membrane, exosomes as drug carriers for augmented targeting, prolonged circulation, and improved biostability—were concluded. Subsequently, the latest application in the treatment of tumors and inflammation was elaborated upon, followed by a discussion of the future prospects to neutrophil-derived delivery systems. This promising system will provide new therapeutic avenues for the treatment of inflammation and tumors.

15 December 2022 in Journal of Controlled Release
Verified
Journal Article
Closed access
HWHuaiji Wang
Huaiji Wang
CWChenghao Wu
Chenghao Wu
XTXiaowen Tong
Xiaowen Tong
SCShunjie Chen
Shunjie Chen

1 September 2022 in International Journal of Nanomedicine
Verified
Journal Article
Open access
PDF file
HWHuaiji Wang
Huaiji Wang
ZZZihan Zhao
Zihan Zhao
CWChenghao Wu
Chenghao Wu
XTXiaowen Tong
Xiaowen Tong
YSYuling Shi
Yuling Shi
SCShunjie Chen
Shunjie Chen
Introduction: Transdermal drug delivery provides a desirable alternative method of penetrating the skin for psoriasis treatment, by virtue of its ability to dampen the overactivation of immune cells and inflammation, while attenuating the detrimental effects of systemic administration. Lymph nodes (LNs), as a critical organ of the lymphatic and the acquired immune system, are suitable sites for drug homing to suppress the immune cells. Methods: In this context, we developed a microneedle (MN) patch that delivers nanodrugs locally to LNs for improving the antipsoriatic treatment. In this study, human serum albumin nanoparticles carrying methotrexate (HM) were synthesized and loaded into hyaluronic acid (HA)-based microneedles (HM/MN). Results: The patch showed an excellent ability to pierce the skin, which enhanced drug delivery. In a mouse model of psoriasis, the HM/MN patch significantly prevented the erythema with decreased skin thickness, thus inhibiting the progression of psoriasis. Further analysis for immune cells in LNs, the percent of dendritic cells (DC) and T cells reduced after the local treatment with HM/MN. Notably, the feasibility of targeted delivery of methotrexate to LNs using nanoparticles was verified by detecting increased accumulation of methotrexate in LNs. In addition, the HM/MN patch pronouncedly decreased the levels of tumor necrosis factor α and interleukin 6 in the skin. Conclusion: The results suggested the high efficacy of using the HM/MN patch to treat psoriasis, and provided new insight into the mechanism of the transdermal drug delivery system.

1 November 2021 in Experimental Gerontology
Verified
Journal Article
Closed access
ZBZhixiang Bian
Zhixiang Bian
RZRui Zhu
Rui Zhu
SCShunjie Chen
Shunjie Chen

14 October 2021 in Frontiers in Molecular Biosciences
Verified
Journal Article
Open access
ZHZhenyuan Han
Zhenyuan Han
XZXiaodong Zhuang
Xiaodong Zhuang
BYBiao Yang
Biao Yang
LJLihui Jin
Lihui Jin
PHPengjie Hong
Pengjie Hong
ZTZhen Tian
Zhen Tian
Objectives: Gliomas remain one of serious public health problems worldwide which demand further and deeper investigation. The aim of this study was to explore the association between synapse defective protein 1 homolog 1 (SYDE1) and gliomas via public database analysis and in vitro validation to determine the potential diagnostic and prognostic values.Methods and Results: Compared with healthy brain tissues, there was a significant increase in SYDE1 expression in glioma tissues. Additionally, SYDE1 exhibited higher expression levels in glioma patients with unfavorable clinicopathological factors. In vitro knockdown of SYDE1 in glioma cell lines A172 inhibited their migrative and invasive ability but not the proliferative ability. GO and KEGG pathway analysis of the top 100 genes coexpressed with SYDE1 showed enrichments of tumor-associated terms. Further bioinformatic analysis revealed that the SNHG16/hsa-miR-520e/SYDE1 axis might be involved in glioma development.Conclusions:SYDE1 is expressed at higher levels in gliomas than in healthy brains, and can promote metastasis and invasion but not proliferation of gliomas. Furthermore, SYDE1 has values in the diagnosis and prognosis prediction of gliomas.

17 August 2024 in The American Journal of the Medical Sciences
Verified
Journal Article
Closed access
XXXin Xu
Xin Xu
BYBuwei Yu
Buwei Yu
YLYouwen Lv
Youwen Lv
QCQing Cai
Qing Cai
MLMengya Li
Mengya Li
QLQifang Li
Qifang Li